Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Arthritis and Rheumatism|April 5, 2002
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritisJosé Hernández-Rodríguez, Ana García-Martínez, Jordi Casademont, et al.
Annals of Internal Medicine|May 2, 2007
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trialGary S Hoffman, Maria C Cid, Karen E Rendt-Zagar, et al.
Rheumatology (Oxford, England)|October 20, 2019
Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosisHelena Florez, José Hernández-Rodríguez, Africa Muxi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 6, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell ArteritisKaitlin A Quinn, Sovira Tan, Pauline Verdijk, et al.
Autoimmunity Reviews|October 31, 2021
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forumAndreas Kronbichler, Duvuru Geetha, Rona M Smith, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2023
The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseasesBalazs Odler, Johanna Tieu, Katharina Artinger, et al.
Annals of the Rheumatic Diseases|September 21, 2012
Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritisGeorgina Espígol-Frigolé, Marc Corbera-Bellalta, Ester Planas-Rigol, et al.
Autoimmunity Reviews|May 23, 2024
Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeuticsShuang Xu, William F Jiemy, Elisabeth Brouwer, et al.
Pageof 15